aTyr Pharma

$3.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.11%) Today

+$0.10 (+2.82%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell aTyr Pharma and other stocks, options, and ETFs commission-free!

About LIFE

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. It operates in a single accounting segment. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA. The listed name for LIFE is aTyr Pharma, Inc. Common Stock.

CEO

Sanjay S. Shukla

Employees

Headquarters

San Diego, California

Founded

2005

Market Cap

36.16M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

107.04K

High Today

$3.70

Low Today

$3.52

Open Price

$3.64

Volume

46.29K

52 Week High

$7.62

52 Week Low

$2.13

Collections

LIFE Earnings

-$2.74

-$1.74

-$0.75

$0.25

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 25, After Hours